Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nature ; 409(6817): 207-11, 2001 Jan 11.
Artigo em Inglês | MEDLINE | ID: mdl-11196646

RESUMO

Metastatic melanoma is a deadly cancer that fails to respond to conventional chemotherapy and is poorly understood at the molecular level. p53 mutations often occur in aggressive and chemoresistant cancers but are rarely observed in melanoma. Here we show that metastatic melanomas often lose Apaf-1, a cell-death effector that acts with cytochrome c and caspase-9 to mediate p53-dependent apoptosis. Loss of Apaf-1 expression is accompanied by allelic loss in metastatic melanomas, but can be recovered in melanoma cell lines by treatment with the methylation inhibitor 5-aza-2'-deoxycytidine (5aza2dC). Apaf-1-negative melanomas are invariably chemoresistant and are unable to execute a typical apoptotic programme in response to p53 activation. Restoring physiological levels of Apaf-1 through gene transfer or 5aza2dC treatment markedly enhances chemosensitivity and rescues the apoptotic defects associated with Apaf-1 loss. We conclude that Apaf-1 is inactivated in metastatic melanomas, which leads to defects in the execution of apoptotic cell death. Apaf-1 loss may contribute to the low frequency of p53 mutations observed in this highly chemoresistant tumour type.


Assuntos
Apoptose , Melanoma/metabolismo , Proteínas/metabolismo , Antineoplásicos/farmacologia , Fator Apoptótico 1 Ativador de Proteases , Caspase 9 , Caspases/metabolismo , Cromossomos Humanos Par 12 , Clonagem Molecular , Metilação de DNA , DNA de Neoplasias/metabolismo , Doxorrubicina/farmacologia , Regulação Neoplásica da Expressão Gênica , Genes Supressores de Tumor , Genes p53 , Humanos , Perda de Heterozigosidade , Melanoma/patologia , Melanoma/secundário , Mutação , Proteínas/genética , Células Tumorais Cultivadas
2.
Cell ; 91(6): 789-98, 1997 Dec 12.
Artigo em Inglês | MEDLINE | ID: mdl-9413988

RESUMO

The effects of pituitary-derived melanocortin peptides are primarily attributed to ACTH-mediated adrenocortical glucocorticoid production. Identification of a widely distributed receptor for ACTH/MSH peptides, the melanocortin-5 receptor (MC5-R), suggested non-steroidally mediated systemic effects of these peptides. Targeted disruption of the MC5-R produced mice with a severe defect in water repulsion and thermoregulation due to decreased production of sebaceous lipids. High levels of MC5-R was found in multiple exocrine tissues, including Harderian, preputial, lacrimal, and sebaceous glands, and was also shown to be required for production and stress-regulated synthesis of porphyrins by the Harderian gland and ACTH/MSH-regulated protein secretion by the lacrimal gland. These data show a requirement for the MC5-R in multiple exocrine glands for the production of numerous products, indicative of a coordinated system for regulation of exocrine gland function by melanocortin peptides.


Assuntos
Glândulas Exócrinas/fisiologia , Receptores da Corticotropina/deficiência , Receptores da Corticotropina/genética , Animais , Regulação da Temperatura Corporal , Feminino , Biblioteca Genômica , Glândula de Harder/fisiologia , Aparelho Lacrimal/fisiologia , Masculino , Camundongos , Camundongos Knockout , Camundongos Transgênicos , Especificidade de Órgãos , Pênis , Porfirinas/metabolismo , RNA Mensageiro/biossíntese , Ratos , Receptores da Corticotropina/biossíntese , Receptores de Melanocortina , Glândulas Sebáceas/fisiologia , Transcrição Gênica , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...